Several studies have demonstrated that autophagy that could be induced by anticancer therapies acted as a novel mechanism of chemoresistance by modifying P62 and LC3 and promoted cancer cell death (Lee et al., 2015; Zanotto-Filho et al., 2015; Yoshida, 2017). Here, MAP1LC3A is linked to cancer.